Importer of Controlled Substances Application: Catalent CTS, LLC, 52509 [2015-21464]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 168 / Monday, August 31, 2015 / Notices
to which the United States is a party
(including grand jury proceedings), or
for the purpose of securing compliance
with this Final Judgment, or as
otherwise required by law.
(D) If, at the time information or
documents are furnished by Defendants
to Plaintiff, Defendants represent and
identify in writing the material in any
such information or documents to
which a claim of protection may be
asserted under Rule 26(c)(1) of the
Federal Rules of Civil Procedure, and
Defendants mark each pertinent page of
such material, ‘‘Subject to claim of
protection under Rule 26(c)(1) of the
Federal Rules of Civil Procedure,’’ then
the United States shall give ten (10)
calendar days’ notice prior to divulging
such material in any legal proceeding
(other than a grand jury proceeding) to
which Defendants are not a party.
VII. RETENTION OF JURISDICTION
This Court retains jurisdiction to
enable any party to this Final Judgment
to apply to this Court at any time for
such further orders and directions as
may be necessary or appropriate to carry
out or construe this Final Judgment, to
modify or terminate any of its
provisions, to enforce compliance, and
to punish any violations of its
provisions.
VIII. EXPIRATION OF FINAL
JUDGMENT
This Final Judgment shall expire five
(5) years from the date of its entry,
except that, if, during the term of this
Final Judgment, the Exemption is
replaced by a Flat Exemption, then the
Final Judgment shall expire on the date
that the Flat Exemption is effective.
IX. COSTS
Each party shall bear its own costs.
X. PUBLIC INTEREST
DETERMINATION
The entry of this Final Judgment is in
the public interest.
DATED:
tkelley on DSK3SPTVN1PROD with NOTICES
Court approval subject to the
Antitrust Procedures and Penalties Act,
15 U.S.C. 16
United States District Judge
[FR Doc. 2015–21534 Filed 8–28–15; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
16:19 Aug 28, 2015
Jkt 235001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Catalent CTS, LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before
September 30, 2015. Such persons may
also file a written request for a hearing
on the application pursuant to 21 CFR
1301.43 on or before September 30,
2015.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments
and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on May 7,
2015, Catalent CTS, LLC, 10245
Hickman Mills Drive, Kansas City,
Missouri 64137 applied to be registered
as an importer of Marihuana (7360), a
basic class of controlled substance listed
in schedule I.
The company plans to import finished
pharmaceutical products containing
cannabis extracts in dosage form for
clinical trial studies.
ADDRESSES:
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
52509
This compound is listed under drug
code 7360. No other activity for this
drug code is authorized for this
registration. Approval of permits
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under to 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
Dated: August 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–21464 Filed 8–28–15; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Alltech Associates, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before September 30, 2015. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
September 30, 2015.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
DATES:
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 80, Number 168 (Monday, August 31, 2015)]
[Notices]
[Page 52509]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-21464]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Catalent CTS, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before September 30, 2015. Such persons may also file
a written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before September 30, 2015.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODXL,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
Comments and requests for hearings on applications to import narcotic
raw material are not appropriate. 72 FR 3417 (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on May 7,
2015, Catalent CTS, LLC, 10245 Hickman Mills Drive, Kansas City,
Missouri 64137 applied to be registered as an importer of Marihuana
(7360), a basic class of controlled substance listed in schedule I.
The company plans to import finished pharmaceutical products
containing cannabis extracts in dosage form for clinical trial studies.
This compound is listed under drug code 7360. No other activity for
this drug code is authorized for this registration. Approval of permits
applications will occur only when the registrant's business activity is
consistent with what is authorized under to 21 U.S.C. 952(a)(2).
Authorization will not extend to the import of FDA approved or non-
approved finished dosage forms for commercial sale.
Dated: August 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-21464 Filed 8-28-15; 8:45 am]
BILLING CODE 4410-09-P
